Capricor Therapeutics (CAPR) Non Operating Interest Expenses (2013 - 2017)
Powered by 
Analysis
Capricor Therapeutics (CAPR) Non Operating Interest Expenses (2013 - 2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.56 Bn | 77.56 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.27 Bn | 53.13 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.35 Bn | 32.04 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.38 Bn | 27.54 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Capricor Therapeutics | 543.35 Mn | 543.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 80,307.00 |
| Sep 30, 2017 | 107,653.00 |
| Jun 30, 2017 | 105,527.00 |
| Mar 31, 2017 | 105,320.00 |
| Dec 31, 2016 | 102,905.00 |
| Sep 30, 2016 | 98,749.00 |
| Jun 30, 2016 | 76,887.00 |
| Mar 31, 2016 | 66,125.00 |
| Dec 31, 2015 | 63,583.00 |
| Sep 30, 2015 | 61,681.00 |
| Jun 30, 2015 | 61,681.00 |
| Mar 31, 2015 | 61,681.00 |
| Dec 31, 2014 | 60,383.00 |
| Sep 30, 2014 | 60,091.00 |
| Jun 30, 2014 | 54,704.00 |
| Mar 31, 2014 | 25,327.00 |
| Dec 31, 2013 | 24,859.00 |
| Sep 30, 2013 | 23,353.00 |
| Jun 30, 2013 | 6,211.00 |
| Mar 31, 2013 | 3,711.00 |